Center for Global Infectious Disease Research
Accelerating Progress Toward Cures
Dr. Nana Minkah who contracted malaria multiple times as a child now dedicates life's work to eliminating this deadly disease.
Our scientists are investigating how a baby's microbiome may offer protection from HIV. “If we can first determine the protective mechanism benefiting babies exclusively fed breast milk, we can design better prevention strategies, such as a vaccine.”
Learn about a unique tool and experimental workflow developed by our scientists to measure the many parameters of cell growth on single cells as they grow into colonies. Story written by CGIDR senior research scientist, Fred Mast.
Dr. Shuyi Ma shares her reaction to the news that her undergraduate mentor became the fifth woman in history to receive the Nobel Prize in Chemistry and shares how her mentor helped shaped her career.
Center for Infectious Disease Research Joins Seattle Children’s Research Institute
Collaborations and partnerships are integral to CGIDR’s approach. Our investigators work closely with colleagues at the University of Washington, Fred Hutchinson Cancer Research Center and other institutions.
Participate in Research
Help us answer questions about childhood health and illness, and help other children in the future. Learn more.
Developing groundbreaking treatments takes more than just the right ideas. It also takes the right people – and the CGIDR is recruiting new members.
Answering your questions about malaria
Drs. Alexis Kaushansky, Ashley Vaughan and Maria Bernabeu Aznar answered questions about malaria in a Reddit Ask Me Anything on April 25, World Malaria Day.
- CGIDR awards five catalytic projects
These five projects deemed to be catalytic because they are innovative, demonstrate the potential for new funding and promote new collaborations between the center’s researchers and laboratories.
What makes a particular hepatocyte attractive to the malaria parasite? – Science in Seattle
A new study in Cell Reports led by Drs. Alexis Kaushansky and Elizabeth Glennon found that higher levels of RPS6 are associated with susceptibility to infection.